NCT05805085 is a NA clinical trial of Lens A in Astigmatism, sponsored by CooperVision, Inc..

Who is sponsoring NCT05805085?

NCT05805085 is sponsored by CooperVision, Inc..

What drugs are being tested in NCT05805085?

Interventions in NCT05805085: Lens A, Lens B.

What condition does NCT05805085 study?

NCT05805085 studies Astigmatism.

Is NCT05805085 still recruiting?

NCT05805085 is currently completed. Last updated 12 December 2024.

Are results published for NCT05805085?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-12-12 · How we verify

NCT05805085

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Hydrogel and Silicone Hydrogel Daily Disposable Toric Contact Lenses

Completed NA Results posted Last updated 12 December 2024

What this trial tests

NA trial testing Lens A in Astigmatism in 40 participants. Completed in 16 November 2023.

Timeline

10 January 2023

Primary endpoint
16 November 2023

16 November 2023

Quick facts

Lead sponsor	CooperVision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	10 January 2023
Primary completion	16 November 2023
Estimated completion	16 November 2023
Sites	1 location across Spain

Drugs / interventions tested

Lens A
Lens B

Conditions studied

Astigmatism — all drugs for Astigmatism →

Sponsor

CooperVision, Inc.

Who can join

Adults 18 to 40, any sex, with Astigmatism. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Subjective Handling at Insertion, Dispensing Visit Primary · 15 minutes

Subjective handling an lens insertion was assessed at the dispending visit using a 0-100 scale, where 100=Excellent, very easy; 0=Very difficult to manage. Collected once at the end of 15 minutes of wear.

Group	Value	95% CI
Lens A	87.13	± 13.68
Lens B	88.50	± 10.14

Subjecting Handling at Insertion, Follow-up Visit Primary · 15 minutes

Subjective handling at lens insertion was assessed at the follow-up visit using a 0-100 scale, where 100=Excellent, very easy; 0=Very difficult to manage. Collected once at the end of 15 minutes of wear.

Group	Value	95% CI
Lens A	92.63	± 9.28
Lens B	90.13	± 9.97

Sponsor's own description

This study was to evaluate the patient subjective experiences of two daily disposable toric contact lenses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lens A

Trials testing the same drug.

NCT05688657 — Clinical Evaluation of Two Toric Contact Lenses · NA · completed
NCT05656885 — Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses · NA · completed
NCT05516082 — Clinical Evaluation of Two Daily Disposable Lenses in Sphere Design · NA · completed
NCT05457608 — Clinical Evaluation of Two Multifocal Contact Lenses · NA · completed
NCT04831515 — Performance Evaluation of Two Daily Disposable Toric Lens Designs in Habitual Soft Contact Lens Wearers · NA · completed

Other recruiting trials for Astigmatism

Currently open trials in the same condition.

NCT07303920 — Wear Experience With Daily Disposable Contact Lenses for Astigmatism Over a Long-Wear Day · NA · recruiting
NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07084844 — Patient Reported Outcomes With WaveLight Plus LASIK · recruiting
NCT07140653 — Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery · Phase 4 · recruiting

Other CooperVision, Inc. trials

Trials by the same sponsor.

NCT06817785 — Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere · NA · completed
NCT06758076 — A Clinical Comparison of Two Soft Contact Lenses (C24-755) · NA · completed
NCT06590441 — Investigation of Wearing Compliance of Spectacles for Myopia Control · completed
NCT06609018 — Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses · NA · completed
NCT06611410 — 1 Week Crossover Study Between Two Soft Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05805085 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CooperVision, Inc.
Last refreshed: 12 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05805085.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing